The Journal of Clinical Endocrinology & Metabolism · 1992 · 24 citations · 16 references
HypertensionCellular PhysiologyCalcium IonophoresOxidative StressAngiogenesisEt ProductionMicrovascular DysfunctionCell SignalingAtherosclerosisMechanobiologyMolecular PhysiologyPhysical TraumaVascular PharmacologyVascular BiologyEndothelin ProductionNeovascularizationPharmacologyCell BiologyUnique Inhibitory ActionSignal TransductionCardiovascular DiseasePhysiologyEndothelial DysfunctionWound HealingHuvec Et ProductionMedicine
Endothelins (ETs) are a recently discovered family of small proteins that have potent long-lasting vasoconstrictive activities. Increased circulating concentrations of ETs have been found in hypertensive and renal disorders, including pregnancy-induced hypertension (PIH). PIH has been postulated to be the end result of endothelial cell damage and aberrant calcium metabolism. We evaluated the effects of calcium ionophores, calcium channel blockers, and two forms of cellular damage on ET production by human umbilical vein endothelial cells (HUVEC). Cells were grown to confluence and then incubated for 16 h with these treatments: physical trauma ("scratching"), oxidant damage (hydrogen peroxide, 1-20 mM), ionomycin (0.25-2.0 microM), A-23187 (10(-9)-10(-5) M), verapamil (0.22-22.0 microM), and nifedipine (2-200 micrograms/mL). ET production was determined using a commercial RIA that detects ET-1 and ET-2. Physical trauma enhanced ET production, whereas oxidant damage had the opposite effect. Both ionomycin and A-23187 caused concentration-dependent inhibition of ET production. Neither verapamil nor nifedipine consistently altered ET production. We conclude that specific forms of cellular damage can stimulate HUVEC ET production, although oxidant damage may be slightly inhibitory. Thus, enhanced ET levels in PIH may represent endothelial cell activation, rather than damage. HUVEC ET production is regulated in an inverse manner by intracellular calcium concentrations, suggesting a negative feedback from mediators of ET action on cells.
16
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Masashi Yanagisawa, Hiroki Kurihara, Sadao Kimura et al. · Nature · 1988 · 10.8K citations
Preeclampsia: An endothelial cell disorder
James Roberts, Robert N. Taylor, Thomas J. Musci et al. · American Journal of Obstetrics and Gynecology · 1989 · 1.9K citations
Endothelial Cell Disorder, Hypertension, Vascular Disease +10
Gilberto De Nucci, Ranjeny Thomas, Pedro D’Orléans-Juste et al. · Proceedings of the National Academy of Sciences · 1988 · 1.4K citations · Full text
Endothelium-derived Relaxing Factor, Pulmonary Arterial Hypertension, Pulmonary Circulation +14
M. Samantha Lewis, Ralph E. Whatley, Patricia Cain et al. · Journal of Clinical Investigation · 1988 · 417 citations · Full text
Lipid Peroxidation, Immunology, Platelet-activating Factor +25